Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Diabetes mellitus and tuberculosis: programmatic management issues.

Harries AD, Kumar AM, Satyanarayana S, Lin Y, Zachariah R, Lönnroth K, Kapur A.

Int J Tuberc Lung Dis. 2015 Aug;19(8):879-86. doi: 10.5588/ijtld.15.0069.

2.

Costs of diagnostic algorithms: whose perspective counts?

Lönnroth K.

Int J Tuberc Lung Dis. 2015 Aug;19(8):878. doi: 10.5588/ijtld.15.0524. No abstract available.

PMID:
26162351
3.

WHO's new end TB strategy.

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H, Gilpin C, Glaziou P, Grzemska M, Mirzayev F, Nakatani H, Raviglione M; WHO's Global TB Programme.

Lancet. 2015 May 2;385(9979):1799-801. doi: 10.1016/S0140-6736(15)60570-0. Epub 2015 Mar 24. No abstract available.

PMID:
25814376
4.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014.

5.

Colliding epidemics requires collaborating programmes.

Lönnroth K.

Lancet Diabetes Endocrinol. 2015 May;3(5):306-7. doi: 10.1016/S2213-8587(15)00037-6. Epub 2015 Mar 6. No abstract available.

PMID:
25754413
6.

Pre-entry, post-entry, or no tuberculosis screening?

van der Werf MJ, Lönnroth K.

Lancet Infect Dis. 2014 Dec;14(12):1171-2. doi: 10.1016/S1473-3099(14)70998-3. Epub 2014 Nov 7. No abstract available.

7.

Toward tuberculosis elimination in low-incidence countries: reflections from a global consultation.

Lönnroth K, Migliori GB, Raviglione M.

Ann Intern Med. 2014 Nov 4;161(9):670-1. doi: 10.7326/M14-1888. No abstract available.

PMID:
25364889
8.

Choosing algorithms for TB screening: a modelling study to compare yield, predictive value and diagnostic burden.

Van't Hoog AH, Onozaki I, Lonnroth K.

BMC Infect Dis. 2014 Oct 19;14:532. doi: 10.1186/1471-2334-14-532.

9.

Mass prophylaxis of tuberculosis through social protection.

Lönnroth K, Weil DE.

Lancet Infect Dis. 2014 Nov;14(11):1032-4. doi: 10.1016/S1473-3099(14)70964-8. Epub 2014 Oct 7. No abstract available.

PMID:
25303846
10.

Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.

Lönnroth K, Glaziou P, Weil D, Floyd K, Uplekar M, Raviglione M.

PLoS Med. 2014 Sep 22;11(9):e1001693. doi: 10.1371/journal.pmed.1001693. eCollection 2014 Sep. Review.

11.

The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets.

Odone A, Houben RM, White RG, Lönnroth K.

Lancet Diabetes Endocrinol. 2014 Sep;2(9):754-64. doi: 10.1016/S2213-8587(14)70164-0. Review.

PMID:
25194888
12.

Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice.

Lönnroth K, Roglic G, Harries AD.

Lancet Diabetes Endocrinol. 2014 Sep;2(9):730-9. doi: 10.1016/S2213-8587(14)70109-3. Review.

PMID:
25194886
13.

Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.

Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, Lönnroth K, Evans CA.

PLoS Med. 2014 Jul 15;11(7):e1001675. doi: 10.1371/journal.pmed.1001675. eCollection 2014 Jul.

14.

China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data.

Wei X, Zou G, Walley J, Yin J, Lonnroth K, Uplekar M, Wang W, Sun Q.

PLoS One. 2014 Mar 12;9(3):e90596. doi: 10.1371/journal.pone.0090596. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e99150.

15.

Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.

Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K.

Eur Respir J. 2014 Jun;43(6):1763-75. doi: 10.1183/09031936.00193413. Epub 2014 Feb 13. Review.

16.

Economic support to patients in HIV and TB grants in rounds 7 and 10 from the global fund to fight AIDS, tuberculosis and malaria.

Richter LM, Lönnroth K, Desmond C, Jackson R, Jaramillo E, Weil D.

PLoS One. 2014 Jan 28;9(1):e86225. doi: 10.1371/journal.pone.0086225. eCollection 2014.

17.

Programmatic approaches to screening for active tuberculosis.

Uplekar M, Creswell J, Ottmani SE, Weil D, Sahu S, Lönnroth K.

Int J Tuberc Lung Dis. 2013 Oct;17(10):1248-56. doi: 10.5588/ijtld.13.0199.

PMID:
24025375
18.

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.

Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A.

Lancet Infect Dis. 2013 May;13(5):436-48. doi: 10.1016/S1473-3099(13)70015-X. Epub 2013 Mar 24. Review.

19.

The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review.

Kranzer K, Afnan-Holmes H, Tomlin K, Golub JE, Shapiro AE, Schaap A, Corbett EL, Lönnroth K, Glynn JR.

Int J Tuberc Lung Dis. 2013 Apr;17(4):432-46. doi: 10.5588/ijtld.12.0743. Review.

PMID:
23485377
20.

Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents.

Mauch V, Bonsu F, Gyapong M, Awini E, Suarez P, Marcelino B, Melgen RE, Lönnroth K, Nhung NV, Hoa NB, Klinkenberg E.

Int J Tuberc Lung Dis. 2013 Mar;17(3):381-7. doi: 10.5588/ijtld.12.0368.

PMID:
23407227
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk